Your browser doesn't support javascript.
loading
Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS.
Porwit, A; van de Loosdrecht, A A; Bettelheim, P; Brodersen, L Eidenschink; Burbury, K; Cremers, E; Della Porta, M G; Ireland, R; Johansson, U; Matarraz, S; Ogata, K; Orfao, A; Preijers, F; Psarra, K; Subirá, D; Valent, P; van der Velden, V H J; Wells, D; Westers, T M; Kern, W; Béné, M C.
Afiliación
  • Porwit A; Department of Pathobiology and Laboratory Medicine, University of Toronto, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada.
  • van de Loosdrecht AA; Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Bettelheim P; First Medical Department, Elisabethinen Hospital, Linz, Austria.
  • Brodersen LE; HematoLogics, Inc., Seattle, WA, USA.
  • Burbury K; Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia.
  • Cremers E; Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Della Porta MG; Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, and University of Pavia, Pavia, Italy.
  • Ireland R; King's College Hospital, London, UK.
  • Johansson U; University Hospitals, Bristol, UK.
  • Matarraz S; Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca, Spain.
  • Ogata K; Metropolitan Research Center for Blood Disorders MRC JAPAN, Midorigaoka, Chofu, Tokyo, Japan.
  • Orfao A; Servicio Central de Citometría, Centro de Investigación del Cáncer, Instituto de Biologia Celular y Molecular del Cáncer CSIC/USAL/IBSAL) and Department of Medicine, Universidad de Salamanca, Salamanca, Spain.
  • Preijers F; Department of Hematology, St Radboud University Medical Center, Nijmegen, The Netherlands.
  • Psarra K; Department of Immunology-Histocompatibility, Evangelismos Hospital, Athens, Greece.
  • Subirá D; Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Vienna, Austria.
  • van der Velden VH; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Wells D; HematoLogics, Inc., Seattle, WA, USA.
  • Westers TM; Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Kern W; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Béné MC; Service d'Hématologie Biologique, CHU de Nantes, Nantes, France.
Leukemia ; 28(9): 1793-8, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24919805
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Citometría de Flujo Tipo de estudio: Diagnostic_studies / Guideline País/Región como asunto: Europa Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2014 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Citometría de Flujo Tipo de estudio: Diagnostic_studies / Guideline País/Región como asunto: Europa Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2014 Tipo del documento: Article